PT83389B - Processo para a preparacao de derivados de sulfonilureia uteis como agentes anti-tumurais - Google Patents

Processo para a preparacao de derivados de sulfonilureia uteis como agentes anti-tumurais

Info

Publication number
PT83389B
PT83389B PT83389A PT8338986A PT83389B PT 83389 B PT83389 B PT 83389B PT 83389 A PT83389 A PT 83389A PT 8338986 A PT8338986 A PT 8338986A PT 83389 B PT83389 B PT 83389B
Authority
PT
Portugal
Prior art keywords
tumary
sulfonylury
derivatives
agents
useful
Prior art date
Application number
PT83389A
Other languages
English (en)
Other versions
PT83389A (en
Inventor
James Jeffry Howbert
James Abraham Aikins
Eddie Vi-Ping Tao
Brent Jeffrey Rieder
Gerald Auston Poore
Richard Waltz Harper
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PT83389A publication Critical patent/PT83389A/pt
Publication of PT83389B publication Critical patent/PT83389B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring
PT83389A 1985-09-23 1986-09-16 Processo para a preparacao de derivados de sulfonilureia uteis como agentes anti-tumurais PT83389B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77935485A 1985-09-23 1985-09-23
US88867586A 1986-07-24 1986-07-24

Publications (2)

Publication Number Publication Date
PT83389A PT83389A (en) 1986-10-01
PT83389B true PT83389B (pt) 1989-05-12

Family

ID=27119572

Family Applications (1)

Application Number Title Priority Date Filing Date
PT83389A PT83389B (pt) 1985-09-23 1986-09-16 Processo para a preparacao de derivados de sulfonilureia uteis como agentes anti-tumurais

Country Status (21)

Country Link
EP (1) EP0222475B1 (pt)
JP (1) JPH0662548B2 (pt)
KR (1) KR880000204B1 (pt)
CN (1) CN1013198B (pt)
AU (1) AU587064B2 (pt)
CY (1) CY1659A (pt)
DE (1) DE3667168D1 (pt)
DK (1) DK160981C (pt)
EG (1) EG18046A (pt)
ES (1) ES2001698A6 (pt)
GR (1) GR862353B (pt)
HK (1) HK88692A (pt)
HU (1) HU200597B (pt)
IE (1) IE59588B1 (pt)
IL (1) IL80032A (pt)
MX (1) MX9203126A (pt)
NZ (1) NZ217597A (pt)
PT (1) PT83389B (pt)
SG (1) SG66892G (pt)
SU (1) SU1545939A3 (pt)
UA (1) UA5953A1 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4845128A (en) * 1984-06-27 1989-07-04 Eli Lilly And Company N([(4-trifluoromethylphenyl)amino]carbonyl)benzene sulfonamides
CA1331464C (en) * 1987-05-12 1994-08-16 Eli Lilly And Company Anti-tumor method and compounds
HU202487B (en) * 1988-03-04 1991-03-28 Mta Koezponti Kemiai Kutato In Process for producing n-sulfonylureas
IL98784A0 (en) * 1990-07-17 1992-07-15 Lilly Co Eli Heterocyclyl sulfonamide derivatives,process for their preparation and pharmaceutical compositions containing them
US5216026A (en) * 1990-07-17 1993-06-01 Eli Lilly And Company Antitumor compositions and methods of treatment
US5262440A (en) * 1991-12-10 1993-11-16 Eli Lilly And Company Antitumor compositions and methods of treatment
US5258406A (en) * 1991-12-20 1993-11-02 Eli Lilly And Company Sulfonimidamides
US5234955A (en) * 1991-12-20 1993-08-10 Eli Lilly And Company Antitumor compositions and methods of treatment
US5254582A (en) * 1992-02-05 1993-10-19 Eli Lilly And Company Antitumor compositions and methods
US5169860A (en) * 1992-03-13 1992-12-08 Eli Lilly And Company Antitumor compositions and methods of treatment
US5270329A (en) * 1992-12-10 1993-12-14 Eli Lilly And Company Antitumor compositions and methods of treatment
CA2110524A1 (en) * 1992-12-10 1994-06-11 Gerald Burr Grindey Antitumor compositions and methods of treatment
ZA941500B (en) * 1993-03-10 1995-09-04 Lilly Co Eli Antitumor compositions and methods of treatment
US6063911A (en) * 1993-12-01 2000-05-16 Marine Polymer Technologies, Inc. Methods and compositions for treatment of cell proliferative disorders
DE69725794T9 (de) * 1996-08-07 2004-12-16 Tomita Pharmaceutical Co. Ltd., Naruto Granulat zur Abwasserbehandlung
JP3226100B2 (ja) * 1996-08-22 2001-11-05 同和薬品工業株式會社 抗腫瘍剤としてのアリールスルホニルイミダゾロン誘導体
ES2156550B1 (es) * 1999-04-19 2002-02-01 Univ Navarra Publica Derivados de benzo(b) tiofenosulfonamida-1,1-dioxido y su uso como agentes antineoplasicos.
US8772269B2 (en) 2004-09-13 2014-07-08 Eisai R&D Management Co., Ltd. Use of sulfonamide-including compounds in combination with angiogenesis inhibitors
WO2006030941A1 (ja) 2004-09-13 2006-03-23 Eisai R & D Management Co., Ltd. スルホンアミド含有化合物の血管新生阻害物質との併用
JP5134247B2 (ja) * 2004-09-13 2013-01-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホンアミド含有化合物の血管新生阻害物質との併用
WO2006090921A1 (ja) * 2005-02-28 2006-08-31 Eisai R & D Management Co., Ltd. スルホンアミド化合物のリンパ球活性化抑制作用
WO2006090928A1 (ja) * 2005-02-28 2006-08-31 Eisai R & D Management Co., Ltd. スルホンアミド化合物の血管新生阻害物質との新規併用
CN101163468A (zh) * 2005-02-28 2008-04-16 卫材R&D管理有限公司 磺酰胺化合物的新联合用途
EP2015070A4 (en) 2006-04-20 2010-04-21 Eisai R&D Man Co Ltd NEW MARKER AGAINST SENSITIVITY TO A SULFONAMIDE COMPOUND
JP2012136435A (ja) * 2009-03-30 2012-07-19 Eisai R & D Management Co Ltd 腫瘍組織の感受性を検査する方法
CN102993106B (zh) * 2012-12-24 2015-06-17 武汉武药制药有限公司 格列吡嗪的合成新路线
GB201618240D0 (en) * 2016-10-27 2016-12-14 Trade Vehicle Locks Ltd Apparatus for locking a door of a vehicle

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1144259B (de) * 1956-05-29 1963-02-28 Hoechst Ag Verfahren zur Herstellung von Sulfonylharnstoffen
DE1159937B (de) * 1960-06-29 1963-12-27 Heyden Chem Fab Verfahren zur Herstellung von Hydrindensulfonylharnstoffen
US3097242A (en) * 1960-06-29 1963-07-09 Olin Mathieson Hydrindene sulfonylureas
DE1240866B (de) * 1961-06-29 1967-05-24 Heyden Chem Fab Verfahren zur Herstellung von Indolin-6-sulfonylharnstoffen
US4634465A (en) * 1982-07-16 1987-01-06 Ciba-Geigy Corporation Fused N-phenylsulfonyl-N'-pyrimidinylureas and N-phenylsulfonyl-N'triazinylureas
IT1161220B (it) * 1983-04-21 1987-03-18 Montedison Spa Diidro-benzofurano derivati ad attivita' erbicida
US4845128A (en) * 1984-06-27 1989-07-04 Eli Lilly And Company N([(4-trifluoromethylphenyl)amino]carbonyl)benzene sulfonamides

Also Published As

Publication number Publication date
UA5953A1 (uk) 1994-12-29
DK160981B (da) 1991-05-13
IE59588B1 (en) 1994-03-09
AU587064B2 (en) 1989-08-03
SU1545939A3 (ru) 1990-02-23
DK446986A (da) 1987-03-24
JPS6296459A (ja) 1987-05-02
SG66892G (en) 1992-09-04
EP0222475B1 (en) 1989-11-29
ES2001698A6 (es) 1988-06-01
EP0222475A1 (en) 1987-05-20
IL80032A (en) 1992-07-15
HUT46657A (en) 1988-11-28
PT83389A (en) 1986-10-01
MX9203126A (es) 1992-07-01
IE862503L (en) 1987-03-23
CY1659A (en) 1993-05-14
KR880000204B1 (ko) 1988-03-12
HU200597B (en) 1990-07-28
HK88692A (en) 1992-11-20
NZ217597A (en) 1989-06-28
CN1013198B (zh) 1991-07-17
DK160981C (da) 1991-10-28
DE3667168D1 (de) 1990-01-04
CN86106428A (zh) 1987-03-18
JPH0662548B2 (ja) 1994-08-17
KR870003086A (ko) 1987-04-15
AU6294286A (en) 1987-03-26
GR862353B (en) 1987-01-19
EG18046A (en) 1991-08-30
DK446986D0 (da) 1986-09-18

Similar Documents

Publication Publication Date Title
PT83389B (pt) Processo para a preparacao de derivados de sulfonilureia uteis como agentes anti-tumurais
PT82794B (pt) Processo para a preparacao de derivados de 3-fenil-4-cianopirrole uteis como microbicidas
PT81859B (pt) Processo para a preparacao de derivados de tiazolidinodionas
PT83179B (pt) Processo para a preparacao de carbinois aril-piperidinicos
PT83876B (pt) Processo para a preparacao de derivados de butiramida n-substituidos
PT81463B (pt) Processo para a preparacao de novos derivados 5-amino-4-hidroxivalerilo
PT82891B (pt) Processo para a preparacao de isoxazois e furanos fenoxialquilicos heterociclicamente substituidos uteis como agentes anti-virais
PT83152B (pt) Processo para a preparacao de compostos di-t-butilfenoicos
PT82062B (pt) Processo para a preparacao de compostos piridinilimidazolidinona
PT84561B (pt) Processo aperfeicoado para a preparacao de derivados macrolidos
BR8601962A (pt) Processo para a preparacao de compostos
PT83344A (pt) Processo para a preparacao de ypsilon-carbolinas antipsicoticas
PT81840B (pt) Processo para a producao de derivados de cefem uteis como agentes anti-bacterianos
PT82678B (pt) Processo para a preparacao de compostos de cinolina
PT88181A (pt) Processo para a preparacao de derivados aralquilaminoalcoxifenilo
PT84010B (pt) Processo para a preparacao de derivados de pirimidina
PT89195A (pt) Processo para a preparacao de derivados de triazole uteis como agentes anti-fungicos
PT80264B (pt) Processo para a preparacao de derivados de hidroxi-4-2h-1-benzotiopiran-2-onas
PT83462B (pt) Processo para a preparacao de derivados piridinilo uteis como microbicidas
PT85608A (pt) Processo para a preparacao de derivados de fenil-etanolamina
PT83154B (pt) Processo para a preparacao de quinolizino-sulfonamidas
PT83531B (pt) Processo para a preparacao de derivados de dicloroanilina
PT88924A (pt) Processo para a preparacao de derivados de ginkgolidos
PT82712B (pt) Processo para a preparacao de novos derivados de quinolina
BR8602094A (pt) Processo para a preparacao de benzotiazolsulfenamidas

Legal Events

Date Code Title Description
NF3A Restitutio in integrum

Free format text: 20010925 RESTITUTIO IN INTEGRUM